Literature DB >> 9786621

Extrapontine myelinolysis after surgical removal of a pituitary tumour.

R Salvesen1.   

Abstract

Extrapontine myelinolysis is a rare and serious disorder characterized by patches of demyelination in certain areas of the brain. Common sites of involvement are the basal ganglia and the thalamus. The patient most often presents with behavioural abnormalities, including mutism, and extrapyramidal symptoms and signs. The diagnosis is established by magnetic resonance imaging. It usually carries a grave prognosis. The pathogenesis seems to be related to profound hyponatremia that is corrected with infusions of saline. We report a case that underwent surgical removal of a pituitary tumour and subsequently was treated with desmopressin. Probably due to an overdose of this antidiuretic hormone, she became obtunded and was found to have profound hyponatremia. This was corrected with infusions of saline, mostly isotonic. She later developed mental disorientation and mutism, and magnetic resonance imaging demonstrated myelinolysis in the basal ganglia. In the course of several months, she has made some recovery, though still demonstrating some memory deficit.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786621     DOI: 10.1111/j.1600-0404.1998.tb07297.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Isolated extra pontine myelinolysis presenting as acute onset parkinsonism.

Authors:  Imran Rizvi; Mehtab Ahmad; Ankush Gupta; Noorin Zaidi
Journal:  BMJ Case Rep       Date:  2012-10-12

2.  Severe hyponatremia in a patient with schizophrenia associated with prolonged consciousness disturbance.

Authors:  Kunihiko Yasuda; Takatsugu Iwashita; Yosuke Tayama; Yuko Makino; Ayumu Watanabe; Tatsuro Sano; Taisuke Shimizu; Tomonari Ogawa; Koichi Kanozawa; Hajime Hasegawa
Journal:  CEN Case Rep       Date:  2016-10-18

3.  Transient Parkinsonism in isolated extrapontine myelinolysis.

Authors:  Bart Post; W A van Gool; M A J Tijssen
Journal:  Neurol Sci       Date:  2009-05-15       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.